The dual chamber prefilled syringes market is expected to be valued at USD 223.3 million by end of 2028 from a value of USD 130 million in 2020, expanding at a CAGR of 7% over the forecast period. This growth of the market is attributable to growing inclination toward lyophilized drugs and bio-based medicines across the globe. Double-chamber syringes are designed as a drug and device combination product, which enables the reconstitution and administration of drugs in fixed doses.
Thus, dual chamber prefilled syringes finds robust applications across administration of drugs for completion of several time consuming processes including cleaning and sterilization. Rising drugs administration activities along with growing adoption of dual chamber prefilled syringes for better administration is driving growth of its market.
Furthermore, the dual chamber prefilled syringes are witnessing demand from research & development activities for the improved drugs for the diseases such as diabetes and erectile dysfunction. According to the data published by World Health Organization (WHO), the mortality from diabetes from 2000 to 2016 has increased to 5% and counted for 1.6 million deaths in 2016. With this rate, diabetes is becoming seventh leading cause of death. The increasing number of patients suffering from these chronic diseases encouraging investment in research, which in turn is fueling growth of the dual chamber prefilled syringes market.
Request a Sample@ https://qyresearchmedical.com/sample/118927
However, the threat of counterfeit products posing risk to the patients, which is a key factor hampering growth of the market. Furthermore, the factors such as investment for research of newer products coupled with approvals from the Food and Drug Administration (FDA) for biopharmaceuticals are estimated to offer several opportunities for growth during the forecast period. The trend of dual chamber prefilled syringes with integrated safety features among end users is estimated to further drive the market growth during the forecast period.
Based on the material, the glass segment hold the largest share in the overall dual chamber prefilled syringes market in 2020 and is projected to hold significant share over the forecast period. This growth of the segment is attributable to the growing its demand owing to benefits offered by material such as non-reactivity to different drugs. Additionally, the reasonable price of glass syringe boosts its demand and drives further growth of the market.
Based on indication, the hemophilia segment hold the largest share in the overall dual chamber prefilled syringes market in 2020 and is projected to hold significant share over the forecast period. The segmental growth is attributable to the robust number of patients suffering from the diseases across the globe. The number of patients suffering from the condition is significant in North America and Europe owing to better access to improved healthcare in both the regions.
However, the number of diabetic patients is increasing globally and especially in Asia Pacific owing to large population and changing lifestyle.
Based on the product, the <1 ml segment is estimated hold significant share in the overall dual chamber prefilled syringes market owing to larger portion of drugs at a time. Additionally, it is able to provide large portion of drugs, which is witnessing robust demand from patients and caregivers and in turn is driving growth of the market.
Regionally, the North America is projected to hold largest share in the global dual chamber prefilled syringes market and to retain over the forecast period. This growth is attributable to the aging population, coupled with medical device manufacturing capacity. Additionally, the factors such as increased health awareness among consumers, affordability of consumers, and increased per capita spending in the region is driving growth of the regional market.
However, Asia Pacific is anticipated to expand at a faster CAGR in the dual chamber prefilled syringes market over the forecast period owing to increasing health awareness and increasing healthcare spending in the region. Additionally, the manufacturers are focusing to offer affordable products and are getting commercially approved. For instance, one of key players, Otsuka America Pharmaceutical Inc.is focusing on countries in the Asia Pacific to generate its business.
Key Market Players
Key players in the dual chamber prefilled syringes market are Gerresheimer AG, Nipro Corporation, Credence Medsystems, Vetter Pharma, Arte Corporation, and MAEDA INDUSTRY.
The key players in the market are entering into joint development of products programs, collaborations, and partnerships for further development. Additionally, their alliance is helping them to hold strong foothold in the market globally.
Segments Covered in the report
This report forecasts revenue growth at a global, regional & country level and provides an analysis of the market trends in each of the sub-segments from 2019 to 2030. The scope of the report can be defined as:
Dual Chamber Prefilled Syringes Market Report Scope
Segments covered By Material, Application, Product, Indication,Regional Outlook
1 ml-2.5 ml
2.5 ml-5.0 ml
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/118927/1500
You can place an order or ask any questions, please feel free to contact [email protected] | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/